Preterm Premature Rupture of Membrane Clinical Trial
Official title:
Azithromycin Pharmacokinetics and Pharmacodynamics in Pregnancy and Preterm Birth Prevention: Optimizing Dosing to Improve Maternal and Neonatal Outcomes
This is a pilot randomized controlled trial to assess the pharmacokinetics and pharmacodynamics of azithromycin in pregnant singletons admitted with preterm premature rupture of membranes (PPROM) at 24 0/7- 33 0/7. Participants will be randomized 1:1 to either 1000mg azithromycin orally once or 500mg azithromycin orally daily for seven days in addition to standard care.
This is a pilot randomized controlled trial to assess the pharmacokinetics and pharmacodynamics of azithromycin in pregnant singletons admitted with preterm premature rupture of membranes (PPROM) at 24 0/7- 33 0/7. Participants will be randomized 1:1 to either 1000mg azithromycin orally once or 500mg azithromycin orally daily for seven days in addition to standard care. During the course of eight days participants will have serial collection of amniotic fluid, maternal serum; and at delivery, of placenta, membrane, and cord blood. After delivery, neonatal respiratory samples will be collected as well. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04963465 -
The Accuracy of Amniotic Fluid Ferning in the Second Trimester in the Diagnosis of Preterm Prelabor Rupture of Membranes
|
||
| Recruiting |
NCT03992534 -
The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth
|
Phase 1 | |
| Recruiting |
NCT03976063 -
Tocolysis in the Management of Preterm Premature Rupture of Membranes Before 34 Weeks of Gestation
|
Phase 3 | |
| Completed |
NCT01503606 -
Duration of Antibiotics Treatment With Cefazolin and Clarithromycin in Women With Preterm Premature Rupture of Membrane
|
Phase 3 | |
| Recruiting |
NCT04590677 -
Prediction of the Onset of Term and Preterm Labour
|
||
| Recruiting |
NCT04110704 -
Cerclage After Full Dilatation Caesarean Section
|
N/A | |
| Completed |
NCT03473210 -
The Value of Amniopatch in Preterm Premature Rupture of Membranes
|
N/A | |
| Not yet recruiting |
NCT05328817 -
Azithromycin Versus Erythromycin For Preterm Prelabor Rupture of Membranes
|
N/A | |
| Recruiting |
NCT05353153 -
The Psychological Experience of Pathological Pregnancy. Study of the Case of Premature Rupture of Membranes and Evaluation of the Impact of Hypnosis Support
|
N/A | |
| Completed |
NCT03814278 -
Bed Rest After Preterm Premature Rupture of the Membranes
|
N/A | |
| Completed |
NCT04807543 -
Effect of Progesterone on Latent Phase Prolongation in Patients With Preterm Premature Rupture of Membranes
|
Phase 2 | |
| Recruiting |
NCT06443788 -
Trans-perineal Ultrasound in Assessment of PPROMs
|
N/A | |
| Not yet recruiting |
NCT05207800 -
Predictive Value of Maternal Serum Pentraxin 3 (PTX 3) and Heparin-binding Protein (HBP) for Chorioamnionitis in Preterm Premature Rupture of Membranes
|
||
| Recruiting |
NCT04705935 -
Amniochorionic Membrane Cells in the Maternal Blood as a Biomarker for Preterm Birth
|
||
| Not yet recruiting |
NCT06396078 -
Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)
|
Phase 4 | |
| Active, not recruiting |
NCT06074601 -
MIRACLE of LIFE Study
|
||
| Recruiting |
NCT04516226 -
Vaginal Cleansing With Chlorhexidine Gluconate in Women With Preterm Pre-labor Rupture of Membranes
|
N/A | |
| Recruiting |
NCT03306719 -
mtDNA as Novel Biomarker for Intra-amniotic Infection
|
N/A | |
| Not yet recruiting |
NCT06377397 -
Selective Antibiotics When Symptoms Develop Versus Universal Antibiotics for Preterm Neonates
|
Phase 3 | |
| Completed |
NCT04413019 -
Domiciliary Versus Hospital Management of PPROM
|